Objective:

To assess whether injectable, light-responsive hollow-sphere graphitic carbon nitride nanoparticles (hg-C3N4 NPs) could stimulate retinal activity and support visual responses in retinal degeneration without genetic modification or electronic implants.

Approach:

• Nanoparticle design: Researchers developed chloroplast-inspired nanoparticles that respond to light through photoelectrochemical and photothermal mechanisms.
• Safety assessment: After intravitreal injection in wild-type mice, retinal structure, glial activation markers and gene-expression pathways related to retinal health, cell death and inflammation were assessed.
• Visual-response testing: In rd10 mice, researchers measured light-dark behavior and visual evoked potentials (VEPs) four weeks after treatment; ex vivo porcine retina experiments assessed ganglion-cell responses to blue light.

Key Findings:

• At 14 days, treated wild-type mice showed no significant changes in retinal thickness or individual retinal layers, and analyses found no appreciable increase in glial activation or significant differences in the assessed gene-expression pathways.
• In rd10 mice, 3 of 7 nanoparticle-treated animals spent more than 60% of their time in the dark compartment; this preference was not observed in control animals.
• Reproducible VEPs were recorded in 5 of 14 treated eyes (36%) versus 1 of 14 pooled control eyes (7%). The risk-difference confidence interval crossed zero, and responses were smaller and slower than in healthy mice.
• ERG responses remained absent in treated rd10 mice.
• In ex vivo porcine retina, blue-light stimulation increased mean ganglion-cell firing from 5 to 29 Hz and peak-to-peak signal amplitude from 12.0 to 39.1 µV; tetrodotoxin substantially reduced the responses.

Interpretation:

The authors suggest that behavioral and cortical responses in treated rd10 mice arose downstream of conventional photoreceptor-mediated signaling. Porcine-retina results support direct light-driven activation of retinal ganglion cells.

Limitations:

• The work is at an early preclinical stage.
• Relatively high light levels were needed to generate cortical responses.
• The authors note that intravitreal injection may have resulted in limited nanoparticle contact with retinal ganglion cells.
• The VEP responder-rate difference was uncertain because its confidence interval crossed zero.

Conclusion:

The study reports preliminary evidence that light-responsive nanoparticles can activate retinal ganglion cells and produce behavioral and cortical responses in a mouse model of retinal degeneration, while photoreceptor-mediated ERG responses remained absent.

Sources:

• Study described in the provided article context; published in Nature Biomedical Engineering